| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
The Population Council New York, New York 10021
Address requests for reprints to: Dr. Mario Ascoli, Department of Pharmacology, University of Iowa College of Medicine, Iowa City, Iowa 52242–1109.
Abstract
In a recent publication we showed that addition of mouse epidermal growth factor (mEGF) to MA-10 Leydig tumor cells rapidly leads to an increase in the incorporation of [3H]inositol-derived radioactivity into an unusual lipid that was identified as phosphatidylinositol-3,4-bisphosphate (PI-3,4-P2). Other ligands that are known to bind to MA-10 cells, such as hCG and arginine vasopressin, however, did not elicit this effect. Inasmuch as mEGF modulates the differentiated functions of MA-10 cells in a number of ways, our findings raised the possibility that PI-3,4-P2 may be an intracellular mediator of these actions of mEGF.
In an attempt to answer this question, we set out to determine if other ligands increase the labeling of PI-3,4-P2 in MA-10 cells prelabeled with [3H]inositol, and if such ligands mimic the diverse biological actions of mEGF on these cells. The experiments presented herein show that insulin, insulin-like growth factor-I, and transforming growth factor-
increase the labeling of PI-3,4-P2 in MA-10 cells, but only transforming growth factor-
mimics the actions of mEGF on the differentiated functions of MA-10 cells. We conclude that an increase in the labeling of PI-3,4-P2 is not sufficient to elicit these actions of mEGF.
FOOTNOTES
This work was supported by a grant from the NIH (CA-40629; to M.A.).
* Established Researcher from the National Research Council of Argentina (IBYME-CONICET), supported by a fellowship from the Andrew W. Mellon Foundation.
Received for publication January 15, 1990. Revision received February 21, 1990. Accepted for publication February 21, 1990.
This article has been cited by other articles:
![]() |
B. Piotrkowski, C. M Monzon, R. M Pagotto, C. G Reche, M. Besio, C. B Cymeryng, and O. P Pignataro Effects of heme oxygenase isozymes on Leydig cells steroidogenesis J. Endocrinol., October 1, 2009; 203(1): 155 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mondillo, R. M. Pagotto, B. Piotrkowski, C. G. Reche, Z. J. Patrignani, C. B. Cymeryng, and O. P. Pignataro Involvement of Nitric Oxide Synthase in the Mechanism of Histamine-Induced Inhibition of Leydig Cell Steroidogenesis via Histamine Receptor Subtypes in Sprague-Dawley Rats Biol Reprod, January 1, 2009; 80(1): 144 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Manna, S. P. Chandrala, S. R. King, Y. Jo, R. Counis, I. T. Huhtaniemi, and D. M. Stocco Molecular Mechanisms of Insulin-like Growth Factor-I Mediated Regulation of the Steroidogenic Acute Regulatory Protein in Mouse Leydig Cells Mol. Endocrinol., February 1, 2006; 20(2): 362 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Balbis, G. Baquiran, C. Mounier, and B. I. Posner Effect of Insulin on Caveolin-enriched Membrane Domains in Rat Liver J. Biol. Chem., September 17, 2004; 279(38): 39348 - 39357. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chamson-Reig, O. P. Pignataro, C. Libertun, and V. A. R. Lux-Lantos Alterations in Intracellular Messengers Mobilized by Gonadotropin-Releasing Hormone in an Experimental Ovarian Tumor Endocrinology, August 1, 1999; 140(8): 3573 - 3580. [Abstract] [Full Text] |
||||
![]() |
M Brignoni, O. Pignataro, M. Rodriguez, A Alvarez, D. Vega-Salas, E Rodriguez-Boulan, and P. Salas Cyclic AMP modulates the rate of 'constitutive' exocytosis of apical membrane proteins in Madin-Darby canine kidney cells J. Cell Sci., January 5, 1995; 108(5): 1931 - 1943. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |